An eight-week, open-label, prospective case series of acamprosate calcium as monotherapy for patients with comorbid anxiety symptoms and alcohol misuse: an evaluation for alcohol sobriety and anxiolysis

Psychiatry (Edgmont). 2007 Apr;4(4):19-20.
No abstract available